Literature DB >> 29932769

Chronic atorvastatin and exercise can partially reverse established skeletal muscle microvasculopathy in metabolic syndrome.

Kent A Lemaster1, Stephanie J Frisbee2, Luc Dubois3, Nikolaos Tzemos4, Fan Wu5, Matthew T Lewis6, Robert W Wiseman6, Jefferson C Frisbee1.   

Abstract

It has long been known that chronic metabolic disease is associated with a parallel increase in the risk for developing peripheral vascular disease. Although more clinically relevant, our understanding about reversing established vasculopathy is limited compared with our understanding of the mechanisms and development of impaired vascular structure/function under these conditions. Using the 13-wk-old obese Zucker rat (OZR) model of metabolic syndrome, where microvascular dysfunction is sufficiently established to contribute to impaired skeletal muscle function, we imposed a 7-wk intervention of chronic atorvastatin treatment, chronic treadmill exercise, or both. By 20 wk of age, untreated OZRs manifested a diverse vasculopathy that was a central contributor to poor muscle performance, perfusion, and impaired O2 exchange. Atorvastatin or exercise, with the combination being most effective, improved skeletal muscle vascular metabolite profiles (i.e., nitric oxide, PGI2, and thromboxane A2 bioavailability), reactivity, and perfusion distribution at both individual bifurcations and within the entire microvascular network versus responses in untreated OZRs. However, improvements to microvascular structure (i.e., wall mechanics and microvascular density) were less robust. The combination of the above improvements to vascular function with interventions resulted in an improved muscle performance and O2 transport and exchange versus untreated OZRs, especially at moderate metabolic rates (3-Hz twitch contraction). These results suggest that specific interventions can improve specific indexes of function from established vasculopathy, but either this process was incomplete after 7-wk duration or measures of vascular structure are either resistant to reversal or require better-targeted interventions. NEW & NOTEWORTHY We used atorvastatin and/or chronic exercise to reverse established microvasculopathy in skeletal muscle of rats with metabolic syndrome. With established vasculopathy, atorvastatin and exercise had moderate abilities to reverse dysfunction, and the combined application of both was more effective at restoring function. However, increased vascular wall stiffness and reduced microvessel density were more resistant to reversal. Listen to this article's corresponding podcast at https://ajpheart.podbean.com/e/reversal-of-microvascular-dysfunction/ .

Entities:  

Keywords:  microvascular dysfunction; peripheral vascular disease; regulation of blood flow; reversing vascular disease; rodent models of the metabolic syndrome; vascular dysfunction

Mesh:

Substances:

Year:  2018        PMID: 29932769      PMCID: PMC6230898          DOI: 10.1152/ajpheart.00193.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  32 in total

1.  Spatial heterogeneity in skeletal muscle microvascular blood flow distribution is increased in the metabolic syndrome.

Authors:  Jefferson C Frisbee; Fan Wu; Adam G Goodwill; Joshua T Butcher; Daniel A Beard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-07-20       Impact factor: 3.619

Review 2.  Prostaglandins and the control of the circulation.

Authors:  A S Nies
Journal:  Clin Pharmacol Ther       Date:  1986-05       Impact factor: 6.875

Review 3.  Flow motion dynamics of microvascular blood flow and oxygenation: Evidence of adaptive changes in obesity and type 2 diabetes mellitus/insulin resistance.

Authors:  Geraldine F Clough; Katarzyna Z Kuliga; Andrew J Chipperfield
Journal:  Microcirculation       Date:  2017-02       Impact factor: 2.628

4.  Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Robert W Brock; I Mark Olfert; Evan R DeVallance; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-10       Impact factor: 4.733

5.  Improved functional vasodilation in obese Zucker rats following exercise training.

Authors:  Mohamad Sebai; Silu Lu; Lusha Xiang; Robert L Hester
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-17       Impact factor: 4.733

Review 6.  Acute Hyperglycemia Impairs Vascular Function in Healthy and Cardiometabolic Diseased Subjects: Systematic Review and Meta-Analysis.

Authors:  Jordan Loader; David Montero; Christian Lorenzen; Rani Watts; Cindy Méziat; Cyril Reboul; Simon Stewart; Guillaume Walther
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-25       Impact factor: 8.311

7.  Microvessel changes in hypertension measured by Griffonia simplicifolia I lectin.

Authors:  A S Greene; J H Lombard; A W Cowley; F M Hansen-Smith
Journal:  Hypertension       Date:  1990-06       Impact factor: 10.190

8.  11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.

Authors:  F Catella; D Healy; J A Lawson; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

9.  Exercise Training Reverses Structural Microvascular Rarefaction and Improves Endothelium-Dependent Microvascular Reactivity in Rats with Diabetes.

Authors:  Marcus V Machado; Rômulo L Martins; Juliana Borges; Bárbara R Antunes; Vanessa Estato; Aline B Vieira; Eduardo Tibiriçá
Journal:  Metab Syndr Relat Disord       Date:  2016-03-22       Impact factor: 1.894

Review 10.  Combating Combination of Hypertension and Diabetes in Different Rat Models.

Authors:  Talma Rosenthal; Firas Younis; Ariela Alter
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-26
View more
  4 in total

1.  Skeletal muscle energetics are compromised only during high-intensity contractions in the Goto-Kakizaki rat model of type 2 diabetes.

Authors:  Matthew T Lewis; Jonathan D Kasper; Jason N Bazil; Jefferson C Frisbee; Robert W Wiseman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-06-12       Impact factor: 3.619

Review 2.  Skeletal muscle performance in metabolic disease: Microvascular or mitochondrial limitation or both?

Authors:  Jefferson C Frisbee; Matthew T Lewis; Robert W Wiseman
Journal:  Microcirculation       Date:  2018-12-23       Impact factor: 2.628

3.  The development of peripheral microvasculopathy with chronic metabolic disease in obese Zucker rats: a retrograde emergence?

Authors:  Brayden D Halvorson; Nithin J Menon; Daniel Goldman; Stephanie J Frisbee; Adam G Goodwill; Joshua T Butcher; Phoebe A Stapleton; Steven D Brooks; Alexandre C d'Audiffret; Robert W Wiseman; Julian H Lombard; Robert W Brock; I Mark Olfert; Paul D Chantler; Jefferson C Frisbee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-07-29       Impact factor: 5.125

Review 4.  Quantification of Mitochondrial Oxidative Phosphorylation in Metabolic Disease: Application to Type 2 Diabetes.

Authors:  Matthew T Lewis; Jonathan D Kasper; Jason N Bazil; Jefferson C Frisbee; Robert W Wiseman
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.